Rezolsta is indicated, in combination with other antiretroviral medicinal products, for the treatment of human immunodeficiency virus 1 (HIV 1) infection in adults and paediatric patients (aged 6years and older, weighing at least 25 kg).Genotypic testing should guide the use of Rezolsta.